Overview

Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
Study to verify the efficacy and tolerability of Sinusitis Hevert SL tablets compared to placebo in adult patients with acute, uncomplicated rhinosinusitis (inflammation of the nasal and paranasal sinuses).
Phase:
Phase 4
Details
Lead Sponsor:
Hevert-Arzneimittel GmbH & Co. KG